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Abstract: This systematic review and meta-analysis evaluated
the influence of biological implant surface coatings on peri-
implant bone formation in comparison to an uncoated tita-
nium reference surface in experimental large animal models.
The analysis was structured according to the PRISMA criter-
iae. Of the1077 studies, 30 studies met the inclusion criteriae.
Nineteen studies examined the bone implant contact (BIC)
and were included in the meta-analysis. Overall, the mean
increase in BIC for the test surfaces compared to the refer-
ence surfaces was 3.7 percentage points (pp) (95% CI 23.9–
11.2, p 5 0.339). Analyzing the increase in BIC for specific
coated surfaces in comparison to uncoated reference surfa-
ces, inorganic surface coatings showed a significant mean
increase in BIC of 14.7 pp (95% CI 10.6–18.9, p < 0.01), extrac-
ellular matrix (ECM) surface coatings showed an increase of
10.0 pp (95% CI 4.4–15.6, p < 0.001), and peptide coatings
showed a statistical trend with 7.1 pp BIC increase (95% CI
20.8–15.0, p 5 0.08). In this review, no statistically significant
difference could be found for growth factor surface coatings
(observed difference 23.3 pp, 95% CI 216.5–9.9, p 5 0.6). All
analyses are exploratory in nature. The results show a statis-
tically significant effect of inorganic and ECM coatings on
periimplant bone formation. VC 2016 Wiley Periodicals, Inc. J
Biomed Mater Res Part A: 00B:000–000, 2016.
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INTRODUCTION
The application of dental implants for the replacement of
missing teeth increased strongly throughout the last 30
years. Innovations in implant material, design, and surface
structure improved implant stability and shortened healing
periods.1,2 Following implant placement, especially the ini-
tial interaction with proteins and cells is inﬂuenced by the
implant surface.3,4 Most implant surface treatments aim at
enhancing the activity of bone-forming cells and their medi-
ators to increase new bone formation and promote earlier
osseointegration and higher secondary implant stability.
Microstructured implant surfaces showed advantageous
characteristics for bone formation and are the current
standard of surface treatment.5 Besides microtopography,
other biophysical factors such as surface chemistry, surface
charge, and wettability also have an inﬂuence on bone
formation.6
Yet another surface modiﬁcation to further stimulate
osseointegration is the coating of implant surfaces with bio-
logical components.7–9 For bone, these may be organic as
well as inorganic in nature, and both can potentially inﬂu-
ence cellular activity during periimplant healing. In this con-
text, many different types of surface coatings have been
analyzed in recent years. These include coatings with
extracellular matrix (ECM) proteins, peptides, growth fac-
tors, calcium phosphate phases, lipids, and so on. In animal
studies, the application of high dosages of the growth factor
BMP-210 as well as other approaches using ECM compo-
nents like collagen and glycosminoglycans9,11 or peptides
derived from ECM proteins like RGD peptide12 have been
reported to show an effect on bone healing.
While these physiological approaches for enhancing
bone healing hold great appeal as the next generation of
surface modiﬁcations and while numerous studies have
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been conducted to assess their efﬁciency, there is still little
systematic evidence of their effects.
The aim of this systematic review and consecutive meta-
analysis was to systematically analyze large animal studies
conducted between 2003 and 2013, which investigated
bone formation around biological implant surface coatings.
It was analyzed whether coated surfaces show an enhanced
periimplant bone formation in comparison to uncoated tita-
nium surfaces. Furthermore, the degree of enhancement as
measured by the bone implant contact (BIC) was evaluated
in relation to animal-speciﬁc factors of inﬂuence.
MATERIALS AND METODS
Eligibility criteria
The following inclusion criteria were deﬁned: publication
period between January 01, 2003, and December 31, 2013,
English language, large animal studies with a minimum of six
animals/study, and comparison of biological implant surface
coatings to uncoated titanium. Both studies in unimpaired
(healthy) bone and in locally or systemically impaired animal
models were considered. Only studies meeting all the inclu-
sion criteriae were included in the review.
The following exclusion criteria were deﬁned: human,
rodent, and rabbit studies. Studies analyzing only inorganic
surface coatings were excluded, while studies analyzing bio-
logical surface coatings together with inorganic surfaces
were included.
Information sources
A data search in the databases Medline (OvidSP), Biosis,
and Scopus were performed for large animal studies. The
search was limited to the English language and aimed at
studies comparing periimplant bone formation of uncoated
titanium implants to implants coated with biological compo-
nents. The term large animal was deﬁned as follows: pig
(including minipig), dog, sheep, goat, and monkey. It did not
include rodents. The literature search-process was carried
out by an information specialist ofﬁcer (MG) of the main
library of the University of Zurich.
Search
The detailed search terms and the search history protocol
are shown in Table I. The retrieved studies underwent a
deduplication program.
TABLE I. Electronical Search Protocol
# Searches Results
1 Dental implants/ 13,133
2 (dental adj3 implant*).ti,ab. 8848
3 exp dental implantation, endosseous/ 12,976
4 exp denture design/or dental prothesis design.mp. 13,207
5 1 or 2 or 3 or 4 34,175
6 “Prostheses and implants”/or prosthesis design/ 67,367
7 Implants, experimental/ 2417
8 (implant or implants).tw. 105,299
9 6 or 7 or 8 156,751
10 (dental or dentistry).ab,jn,kw,ti,sb. 180,020
11 9 and 10 11,762
12 5 or 11 35,960
13 Coated materials, biocompatible/ 9633
14 ((surfac* or implant*) adj3 (coated or coating or lining or
covering or covered or plating or finishing or loaded
or loading or sputter*)).tw.
19,184
15 ((pulse* or spray* or beam or assisted) adj5 deposit*).tw. 2372
16 exp Biomimetics/ 2916
17 biomimetic*.tw. 5921
18 exp body fluids/ 275,882
19 (body adj3 fluid*).tw. 15,643
20 simulated.tw. 84,250
21 (18 or 19) and 20 2729
22 exp collagen/or collagen.mp. 163,682
23 exp “Intercellular signaling peptides and proteins”/ 756,751
24 ((growth or signaling or intercellular) adj3 (factor* or protein* or peptide*)).tw. 294,412
25 (surface or coated or coating or lining or covering or
covered or plating or finishing or loaded or loading or sputter*).tw.
959,310
26 (22 or 23 or 24) and 25 82,808
27 13 or 14 or 15 or 16 or 17 or 21 or 26 118,482
28 12 and 27 3322
29 Animals/not exp rodentia/ 2,617,285
30 (dog* or canine or hound* or hog* or swine* or pig* or
porcine or cat* or feline or goat* or caprine or sheep* or ovine).tw.
1,794,683
31 29 or 30 3,810,566
32 28 and 31 970
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Study selection
Two investigators (GJ and JJ) each screened half of the titles
and abstracts of all studies for meeting the inclusion or
exclusion criteriae in a ﬁrst round. Disagreement was solved
by discussion between the investigators GJ, JJ, and BS. Full
texts were obtained in cases where titles and abstracts did
not provide sufﬁcient information regarding the inclusion/
exclusion criteria. In a second round, two investigators (GJ
and JJ) each screened half of the remaining studies as full
texts for meeting the inclusion criteria. Disagreement was
solved by discussion between the investigators GJ, JJ, and
BS. Kappa and McNemar test served for the evaluation of
intraexaminer and interexaminer agreement (Fig. 1).
Data collection process and meta-analysis
Full texts of all included studies were analyzed, and data
were extracted and coded in an excel table. Following data
extraction, parameters of analysis were identiﬁed which
enabled a comparison of the study results by means of a
meta-analysis. To gain a better understanding of a potential
effect of biological surface coatings on periimplant bone for-
mation, a meta-analysis of those studies that measured the
effect on the BIC was performed. This served to quantify
possible effects of surface coatings on bone formation. The
meta-analysis was based solely on studies in unimpaired
bone using the analyzed test and control implants that
measured BIC and standard deviation (SD). If BIC was not
reported, the study was excluded from the meta-analysis. If
SD was not reported and minimum (min)/maximum (max)
or the 95% conﬁdence interval (95% CI) was available, SD
was computed based on these parameters by the statistian
(MR). If BIC/SD were only extractable from a graph, the
absolute values were measured from the graph. The meta-
analysis evaluates the difference in BIC between test and
control surfaces with regard to the type of surface coating,
animal species, and implant localization.
Data items
All included studies were analyzed with respect to the fol-
lowing parameters: animal species, systemically impaired/
unimpaired animal model, locally compromised/uncompro-
mised bone, animal number, total implant number, implant
FIGURE 1. PRISMA diagram.
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localization, healing mode, loaded or nonloaded, time points
of examination, number of different surfaces, type of biologi-
cal surface coating, type of titanium reference surface,
method of implant analysis, and BIC.
Risk of bias
A Funnel plot was produced to estimate the publication bias
of the studies in the meta-analysis (Fig. 2).
Summary measures and synthesis of results
Mean and 95% CI of BIC were calculated and included in
the meta-analysis. The parameters effect size and relative
effect were also calculated. Effect size is the absolute BIC
change measured and calculated as the mean difference
between BIC percentage of test and reference surface. The
relative effect is the percentage of the absolute BIC change
(effect size) in relation to the BIC of the reference surface
and is calculated as the following equations:
BICeffect size ð%Þ=BICtest surface ð%Þ
Effect size of each study, as well as the summary effect size
and summary relative effect are shown in the column mean
difference in Figure 3. The mean effect size values were
pooled using random-effect models to calculate a summary
effect size and corresponding two-sided 95% CI. The DerSi-
monian and Laird method was used to estimate the
between studies variance s2. The I2 statistic was also calcu-
lated to estimate the heterogeneity between studies. The
weights per study can be found in column W (random) in
Figure 3. As a result, the summary effect size is the effect
size measured over all studies included in the meta-
analysis. The summary relative effect was calculated as the
absolute value of the summary effect size divided by the
weighted mean of the reference BIC percentage. Results
were considered statistically signiﬁcant if p values were
<0.05. The primary analysis used data from all studies with
all test surfaces and both blasted/etched and polished/
machined reference surfaces. All analyses are exploratory in
nature, as no correction for multiple testing was applied. All
statistical meta-analyses were performed using R v3.1.0 and
the R-package “meta” v4.2-0. The above-described analyses
were calculated by the statistian (MB).
Additional analyses
For descriptive results, the statistical analysis was per-
formed using SPSS (Version 22; IBM, New York). Absolute
and relative frequencies of discrete variables were com-
puted. In addition, the 95% CI for the true proportion was
computed according to Wilsons procedure. For continuous
variables, means and SDs were computed. Intra- and inter-
examiner agreements were investigated by the kappa mea-
sure.13,14 In addition, the McNemar test was applied to
evaluate a possible disagreement between the examiners.
Additional analyses were calculated by the statistian (MR).
RESULTS
Study selection
The literature search revealed a total number of 1394 titles,
of which 1077 titles remained after automatic deduplication.
In the ﬁrst round of screening process, 977 articles were
excluded. Of the remaining 100 studies, a further 70 studies
were excluded in a second round of screening. The ﬁnal 30
studies were included in this systematic review. An over-
view on all included studies is given in Table II. Figure 1
shows the search pathway. Main reasons for exclusion were
the application of rodent or rabbit models, lack of a biologi-
cally modiﬁed test surface or lack of an uncoated titanium
reference surface, pilot studies with less than six animals,
human studies, and entirely different experimental setup,
for example, in vitro studies.
Study characteristics and descriptive results
Experimental details of the 30 studies include animal
parameters (total number, species, and health condition sys-
temic/local), implant parameters (total number, material,
FIGURE 2. Funnel plot of the results showing the standard error versus the mean difference of the studies. Studies with a negative mean differ-
ence and large standard errors seem to be underrepresentated in our analysis, which could be an indicator of a publication bias.
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design, length, diameter, localization, healing mode, and
loading), analysis (time points and method), and implant
surface parameters (number of tested surfaces per study,
type of reference surface, type of test surface, and coating
components).
Animal parameters. The total animal number per study dif-
fered and varied between 6 and 20 (mean 13) animals. The
30 studies used ﬁve different animal species, which in all
cases were unimpaired and systemically healthy. Dog (16)
and pig (9) animal models were most common, and smaller
groups include goat and sheep as well as one monkey
model. Six studies used local defect models. In ﬁve studies,
implants were partly placed supracrestally,15–19 in one a
periimplant gap model11 was created. The remaining 24
studies applied no defect models.
Implant parameters. The applied number of implants per
study showed a range from 24 to 110 implants. The mean
implant number per study was 60. The implant material in
all 30 studies was titanium, two studies further investigated
zirconia implants.6,20 Screw-shaped implants were used in
27 studies, three studies applied experimental implant
designs.12,21,22 The mean implant length was 9 mm. The
mean implant diameter reported in 29 studies was about
4 mm, two studies reported an inner implant diameter of
2.7 mm.23,24 In 23 studies, implants were placed intraorally,
in seven studies extraorally. In general, most implants were
placed into the mandible: In the intraoral studies, implants
in ﬁve studies were placed in the upper jaw and implants in
18 studies in the lower jaw. Within the seven extraoral
studies, in two studies, implants were placed in pelvic bone,
three in skull bone and two in femoral bone. In 29 studies
implants healed submerged (covered by the gingiva), in one
study nonsubmerged. Implants of all 30 studies were
unloaded.
Analysis parameters. All 30 studies used 1, 2, or 3 time
points of analysis (T1, T2, and T3). Implant follow-up time
was up to 168 days. Mean T1 examination time point was
36 days. In 21 studies, a second time point (T2) was ana-
lyzed (mean T2 time point 52 days). In eight studies, a third
examination time point (T3) was analyzed (mean T3 time
point 40 days).
The most common method of analysis for the investiga-
tion of surface effects was qualitative histology and quanti-
tative histomorphometry: BIC and bone volume (BV). Other
methods of analysis were immunohistochemistry, ﬂuoro-
chrome labeling, mechanical testing (removal torque test),
and radiography. Twenty-six studies performed histological
analyses, nine studies performed ﬂuorochrome labeling, one
study used immunohistochemistry, four studies applied
mechanical testing, and 11 studies used radiographic
methods.
Implant surface parameters. Ten different biological sur-
face components could be identiﬁed. The authors allocated
these 10 components to the following four groups: (1) inor-
ganic components, (2) growth factors, (3) peptides, and (4)
ECM components. Details about test and reference surfaces
of all 30 studies are shown in Table III.
FIGURE 3. Overall results of the meta-analysis of all test surfaces compared to all reference surfaces. The mean difference (MD) calculated with
the mean BIC (mean) and standard deviation (SD) of test and reference surfaces shows a summary effect size of 3.68 pp more BIC and a sum-
mary relative effect of 7.5 pp. The summary effect size was calculated using a random effect model, and the weight per study can be found in
column W (random).
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TABLE II. List of All 30 Studies Included in the Systematic Review
Nr Author Year Title
1 Alghamdi et al. 2013 Biological response to titanium implants coated with nanocrystals calcium
phosphate or type 1 collagen in a dog model
2 Barros et al. 2009 Effect of biofunctionalized implant surface on osseointegration: a histomor-
phometric study in dogs
3 de Barros et al. 2013 Bone formation in a local defect around dental implants coated with
extracellular matrix components
4 Ferguson et al. 2008 Biomechanical comparison of different surface modifications for dental
implants
5 Germanier et al. 2006 Enhanced bone apposition around biofunctionalized sandblasted and acid-
etched titanium implant surfaces. A histomorphometric study in minia-
ture pigs
6 Huh et al. 2012 Effects of anodized implants coated with Escherichia coli-derived rhBMP-2
in beagle dogs
7 Huh et al. 2011 Alveolar ridge augmentation using anodized implants coated with Esche-
richia coli-derived recombinant human bone morphogenetic protein2
8 Hunziker et al. 2012 Osseointegration: the slow delivery of BMP-2 enhances osteoinductivity
9 Langhoff et al. 2008 Comparison of chemically and pharmaceutically modified titanium and zir-
conia implant surfaces in dentistry: a study in sheep
10 Leknes et al. 2013 Alveolar ridge augmentation using implants coated with recombinant
human growth/differentiation factor-5 (rhGDF-5): radiographic
observations
11 Liu et al. 2007 The influence of BMP-2 and its mode of delivery on the osteoconductivity
of implant surfaces during the early phase of osseointegration
12 Mueller et al. 2011 Comparative analysis of osseointegration of titanium implants with acid-
etched surfaces and different biomolecular coatings
13 Nikolidakis et al. 2009 The effect of a low dose of transforming growth factor beta1 (TGF-beta1)
on the early bone-healing around oral implants inserted in trabecular
bone
14 Polimeni et al. 2010 Alveolar ridge augmentation using implants coated with recombinant
human growth/differentiation factor-5: histologic observations
15 Ramazanoglu et al. 2011 The effect of combined delivery of recombinant human bone morphoge-
netic protein-2 and recombinant human vascular endothelial growth fac-
tor 165 from biomimetic calcium-phosphate-coated implants on
osseointegration
16 Ramazanoglu et al. 2013 Bone response to biomimetic implants delivering BMP-2 and VEGF: An
immunohistochemical study
17 Schliephake et al. 2005 Effect of immobilized bone morphogenic protein 2 coating of titanium
implants on peri-implant bone formation
18 Schliephake et al. 2009 Effect of modifications of dual acid-etched implant surfaces on peri-
implant bone formation. Part I: organic coatings
19 Schliephake et al. 2009 Effect of modifications of dual acid-etched implant surfaces on peri-
implant bone formation. Part II: calcium phosphate coatings
20 Schliephake et al. 2003 Biological performance of biomimetic calcium phosphate coating of tita-
nium implants in the dog mandible
21 Schliephake et al. 2005 Functionalization of dental implant surfaces using adhesion molecules
22 Schliephake et al. 2006 Biomimetic calcium phosphate composite coating of dental implants
23 Schouten et al. 2009 Effects of implant geometry, surface properties, and TGF-beta1 on peri-
implant bone response: an experimental study in goats
24 Schulz et al. 2014 Coating with artificial matrices from collagen and sulfated hyaluronan
influences the osseointegration of dental implants
25 Stadlinger et al. 2009 Increased bone formation around coated implants
26 Stadlinger et al. 2008 Suitability of differently designed matrix-based implant surface coatings:
an animal study on bone formation
27 Sverzut et al. 2012 Effects of type I collagen coating on titanium osseointegration: histomor-
phometric, cellular and molecular analyses
28 Wikesj€o et al. 2008 Bone formation at recombinant human bone morphogenetic protein-2-
coated titanium implants in the posterior maxilla (type IV bone) in non-
human primates
29 Wikesj€o et al. 2008 Alveolar ridge augmentation using implants coated with recombinant
human bone morphogenetic protein-2: histologic observations
30 Wikesj€o et al. 2008 Bone formation at recombinant human bone morphogenetic protein-2-
coated titanium implants in the posterior mandible (type II bone) in dogs
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Results of individual studies
Defect model studies (excluded from the meta-
analysis). Six studies analyzed implants in different defect
models. For this purpose, periimplant gaps and supraalveo-
lar defects were applied. Especially growth factors were
analyzed in supraalveolar defects.De Barros et al.11 analyzed
bone healing around coated implants in a periimplant gap-
defect model. The test surface consisted of collagen type 2
and chondroitin sulfate, the control surface of sandblasted/
acid-etched titanium. It was concluded that the width of the
periimplant gap inﬂuences periimplant bone formation, and
as a result, lower vertical and horizontal apposition with
increasing bone gap sizes was noticed. In proximity to the
surface, the collagen/CS coating inﬂuenced bone formation
positively.
Five studies15–19 investigated supraalveolar defect mod-
els. BMP-2 was used as a coating component in three of
these studies.15,16,19 The reference surface in all cases was
anodically oxidized titanium. The test surfaces with a
rhBMP-2 surface-coating were on anodically oxidized tita-
nium in all three studies15,16,19; the surface in the Wikesjo
study was further deﬁned as being a porous oxide. The
authors concluded that rhBMP-2 coated anodized implants
could stimulate bone formation and increase stability signif-
icantly on completely healed alveolar ridges in dogs, while
rhBMP-2 on porous oxide implant surfaces induced relevant
local bone formation, including vertical augmentation of the
alveolar ridge and osseointegration.
Two studies used rhGDF-5 as a coating component17,18
with test and control surface both being anodically oxidized
titanium. Different levels of enhancement in bone formation
were described for rhGDF-5.
Non-defect model studies (excluded from the meta-
analysis). Five studies analyzed implants in unimpaired
bone but were not included in the meta-analysis, as these
studies did not perform BIC measurements.
Alghamdi et al.21 used a test surface with nano-CaP and
collagen type 1, and the control surface was pure titanium.
They reported that the obtained data failed to provide an
effect on bone formation of the collagen coating.
TABLE III. Distribution of Surface Coatings
Study R I GF P ECM
1. Alghamdi et al.21 X (*) X (**) X (*)
2. Barros et al.29 X (*) X (*) X (*)
3. de Barros et al.11 X (***) X (**/****)
4. Ferguson et al.20 X (*/***) X (*/***) X (*/****)
5. Germanier et al. (2006) X (*) X (**)
6. Huh et al.15 X (***) X (*)
7. Huh et al.14 X (***) X (*)
8. Hunziker et al.25 X (*) X (**) X (*)
9. Langhoff et al.6 X (*) X (*/***) X (*/****)
10. Leknes et al.17 X (***) X (*****)
11. Liu et al.28 X (*) X (**) X (*)
12. Mueller et al.35 X (*) X (*/**/***) X (*)
13. Nikolidakis et al. (2009) X (*) X (****)
14. Polimeni et al.18 X (*) X (*****)
15. Ramazanoglu et al.23 X (*) X (**) X (*/**)
16. Ramazanoglu et al.24 X (*) X (**) X (*/**)
17. Schliephake et al.36 X (**) X (*) X (*/****)
18. Schliephake et al.9 X (*/**) X (*) X (**) X (*/****)
19. Schliephake et al.30 X (*/**) X (*) X (*)
20. Schliephake et al.22 X (*) X (*) X (*)
21. Schliephake et al.36 X (*) X (**) X (*)
22. Schliephake et al.26 X (*) X (*/**) X (*)
23. Schouten et al.27 X (**) X (**) X (****)
24. Schulz et al. (2014) X (*) X (*/*****)
25. Stadlinger et al. (2009) X (*) X (*/****)
26. Stadlinger et al.12 X (*) X (**) X (*/***)
27. Sverzut et al. (2012) X (*) X (*)
28. Wikesjo et al.10,19,37 X (***) X (*)
29. Wikesjo et al.10,19,37 X (***) X (*****)
30. Wikesjo et al.10,19,37 X (***) X (*)
Titanium reference surface (R): *microrough**–sandblasted/acid-etched (20 studies); **polished–machined (4 studies); and ***pure tita-
nium/anodic oxidation (9 studies). Inorganic surface coating (I): *HA, hydroxyapatite (6 studies); **CaP, calcium phosphate (7 studies); and
***bisphosphonate (2 studies). Growth factors surface coating (GF): *rhBMP-2, recombinant human bone morphogenetic protein2 (11 studies);
**VEGF-165, vascular endothelial growth factor 165 (3 studies); ***FGF-2, fibroblast growth factor 2 (1 study); ****TGF-b1, transforming growth
factor b1 (2 studies); *****rhGDF-5, recombinant human growth differentiation factor 5 (3 studies). Peptide surface coating (P): *bioactive pep-
tide sequence (1 study); **RGD peptide, amino acid sequence: Arg–Gly–Asp (4 studies). Extracellular matrix surface coating (ECM): *collagen
type 1 (14 studies); **collagen type 2 (1 study); ***collagen type 3, (1 study); ****chondroitin sulfate (5 studies); and *****hyaluronic acid (1
study).
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Ferguson et al.20 used test surfaces coated with hydroxy-
apatite, bisphosphonates, collagen type 1/CS, and a sand-
blasted/acid-etched titanium control surface. The authors
concluded that functional surface modiﬁcations such
as bisphosphonates and collagen coatings seem to
enhance early periimplant bone formation. Ferguson et al.
used biomechanical and radiographic analyses without
histomorphometry.
Hunziker et al.25 used test surface coated with CaP and
BMP-2 and a sandblasted/acid-etched titanium control sur-
face. They concluded that the capacity of BMP-2 to induce
local bone formation can be inﬂuenced by its mode of
delivery.
Langhoff et al.6 used a test surface containing hydroxy-
apatite, bisphosphonates, collagen type 1/CS, and a sand-
blasted/acid-etched titanium control surface. There were no
signiﬁcant differences.
Ramazanoglu et al.24 used a test surface containing CaP,
rhBMP-2, rhVEGF-165, and an acid-etched titanium control
surface. It was concluded that a combination of BMP-2 and
VEGF has a beneﬁt on bone mineralization and the expres-
sion of bone matrix proteins.
Results of Funnel plot. Smaller studies with negative
results tend not to be published at all, which seems to be
the case in our analysis (Funnel plot). In other words, the
studies that were selected and included may represent too
positive results.
Synthesis of meta-analysis results
Of the 30 studies of this review, 23 studies measured the
BIC. Seven studies did not measure BIC, but other parame-
ters like histomorphometric BV, radiographic parameters,
and mechanical removal torque tests were thus excluded
from the meta-analysis. The 23 BIC studies contained four
defect animal models, which were also excluded. The ﬁnal
meta-analysis was computed with 19 studies as shown in
Table IV.
Overall results. For all 19 studies and regardless of surface
type, the summary effect size of BIC of the test surface was
3.68 percentage points (pp) higher compared to the refer-
ence surface (95% CI 23.86–11.22, p 5 0.339), which cor-
responds to a summary relative effect increase of 7.5 pp
(Fig. 3). There was a noticeable variation between the stud-
ies (s2 5 244.9).
Analyzing only studies and data for inorganic surface
coatings the mean summary effect size of BIC was 14.71 pp
higher compared to the reference surface (95% CI 10.57–
18.85, p < 0.001), which corresponds to a summary relative
effect increase of 43.8 pp. A smaller but still statistically sig-
niﬁcant difference was found for ECM surface coatings
(summary effect size increase of 9.97 pp, 95% CI 4.37–
15.56, p < 0.001, summary relative effect increase of 21.3
pp). Peptide surface coatings showed a trend toward higher
BIC values for test surface compared to reference surfaces
(summary effect size increase of 7.13 pp, 95% CI 20.81–
15.07, p 5 0.078, summary relative effect increase of
13.5 pp). No statistically signiﬁcant difference between test
and reference surfaces could be found for growth factor sur-
face coatings (summary effect size decrease of 23.32 pp,
95% CI 216.51–9.86, p < 0.621, summary relative effect
decrease of 26.8 pp).
The above data included all types of references surfaces.
Comparable results were found if only studies with micro-
rough titanium reference surfaces were analyzed. For these
TABLE IV. Studies of the Meta-Analysis
Study A GF P ECM
Animal
Model Location
1. Barros et al.29 HA Bioactive
peptide
Dog Mandible
2. Germanier et al. (2006) RGD Pig Maxilla
3. Liu et al.28 CaP BMP-2 Pig Maxilla
4. Mueller et al.35 BMP-2/VEGF-126/FGF-2 Pig Skull
5. Nikolidakis et al. (2009) TGF-b1 Goat Femur
6. Ramazanoglu et al.23 CaP BMP-2/VEGF-126 Pig Skull
7. Schliephake et al.36 BMP-2 Collagen 11CS Dog Mandible
8. Schliephake et al.9 BMP-2 RGD Collagen 11CS Dog Mandible
9. Schliephake et al.30 HA Collagen 1 Dog Mandible
10. Schliephake et al.22 HA Collagen 1 Dog Mandible
11. Schliephake et al.36 RGD Collagen 1 Dog Mandible
12. Schliephake et al.26 HA1CaP Collagen 1 Dog Mandible
13. Schouten et al.27 CaP TGF-b1 Goat Femur
14. Schulz et al. (2014) Collagen 11
hualuronic acid
Pig Maxill
15. Stadlinger et al. (2009) Collagen 11CS Pig Mandible
16. Stadlinger et al.12 RGD Collagen 11 3 Pig Mandible
17. Sverzut et al. (2012) Collagen 1 Dog Mandible
18. Wikesjo et al.10,19,37 BMP-2 Monkey Maxilla
19. Wikesjo et al.10,19,37 BMP-2 Dog Mandible
Table III shows 19 studies with its surface components, animal models, and implant location.
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microrough reference surfaces, though the effect size and
the relative effect on the BIC were generally smaller, the
most pronounced effects were again displayed by inorganic
surface coatings, followed by ECM. The effect of peptide
coatings was again the smallest, and GF also did not result
in a measureable increase in BIC (Table V).
Species. Taking only dog studies into account, signiﬁcant dif-
ferences could be found between the BIC of the reference
surfaces compared to test surfaces for inorganic surface coat-
ings (summary effect size increase of 13.68 pp, 95% CI 8.43–
18.93, summary relative effect increase of 34.2 pp,
p < 0.001), peptide surface coatings (summary effect size
increase: 10.83 pp, 95% CI 4.30–17.35, summary relative
effect increase 24.7 pp, p 5 0.001), and ECM surface coatings
(summary effect size increase: 12.64 pp, 95% CI 6.42–18.86,
summary relative effect increase of 36.2 pp, p < 0.001). No
statistically signiﬁcant difference was observed for dogs with
test surfaces with growth factor coatings (summary effect
size decrease of 28.99 pp, 95% CI 240.28–22.30, summary
relative effect decrease of 15.9 pp, p 5 0.573).
Conversely, considering only studies using pigs a signiﬁ-
cant difference in the mean BIC between the reference and
the test surface with GF coatings was found (summary
effect size increase of 5.85 pp, 95% CI 0.80–10.90, summary
relative effect increase of 24.7 pp, p 5 0.023). The observed
difference for peptide coatings was not statistically signiﬁ-
cant (summary effect size increase of 2.31 pp, 95% CI
29.96–14.59, summary relative effect increase of 3.9 pp,
p 5 0.712), neither was the difference for ECM coatings
(summary effect size increase of 7.18 pp, 95% CI 20.92–
15.27, summary relative effect increase of 13.1 pp,
p 5 0.082). The results for inorganic surface coatings in
pigs were similar to the results in dogs (summary effect
size increase of 14.55 pp, 95% CI 5.08–24.02, summary rel-
ative effect increase of 87.4 pp, p 5 0.003). Two goat stud-
ies were included into the meta-analyses and showed no
statistical signiﬁcant difference (summary effect size
increase of 7.31 pp, 95% CI 226.40–41.02, summary rela-
tive effect increase of 14.1 pp, p 5 0.671). Species speciﬁc
results are shown in Table V.
Location. The test surfaces using inorganic surface coatings
in extraoral locations had a signiﬁcantly higher BIC com-
pared to the reference surfaces (summary effect size
increase of 15.06 pp, 95% CI 6.23–23.89, summary relative
effect increase of 68.4 pp, p 5 0.001). When GF surface
coatings were used, no signiﬁcant effect could be observed
(observed difference summary effect size increase of
7.42 pp, 95% CI 26.79–21.62, summary relative effect
increase of 18.5 pp, p 5 0.306). There were not enough
studies to compare the peptide and ECM coatings in extrao-
ral locations, as only one study examined ECM surface coat-
ings, and no study examined a peptide surface coating in an
extraoral location.
In intraoral locations, test surfaces with inorganic sur-
face coatings (summary effect size increase of 14.54 pp,
95% CI 9.66–19.42, summary relative effect increase of
38.1 pp, p < 0.001) and ECM surface coatings (summary
effect size increase of 9.96 pp, 95% CI 3.75–16.17, summary
relative effect increase of 20.9 pp, p 5 0.002) had a signiﬁ-
cantly higher mean BIC compared with reference surfaces.
No signiﬁcant difference could be observed for GF surface
coatings (summary effect size decrease of 212.29 pp, 95%
CI 232.37–7.79, summary relative effect decrease of
21.7 pp, p 5 0.230) and for peptide surface coatings (sum-
mary effect size increase of 7.13 pp, 95% CI 20.81–15.07,
summary relative effect increase of 13.5 pp, p 5 0.078).
TABLE V. Results of the Meta-Analysis According to Surface Type, Animal Species and Anatomical Locations (*: p-values
were deemed significant if <0.05, without correction for multiple testing)
Species/Location Surface # Studies Effect Size 95% CI Relative Effect (%) p values
All 13 20.06 28.59–8.46 20.1 0.988
Inorganic 4 9.3 3.27–15.34 24.2 0.003*
GF 7 27.93 221.16–5.31 215.7 0.240
Peptide 4 2.23 23.82–8.27 3.9 0.471
ECM 6 7.93 1.07–14.8 15.4 0.024*
Dog Inoragnic 4 13.68 8.43–18.93 34.2 <0.001*
Dog GF 3 28.99 240.28–22.30 215.9 0.573
Dog Peptide 3 10.83 4.30–17.35 24.7 0.001*
Dog ECM 6 12.64 6.42–18.86 36.2 <0.001*
Pig Inorganic 2 14.55 5.08–24.02 87.4 0.003*
Pig GF 3 5.85 0.80–10.90 24.7 0.023*
Pig Peptide 2 2.31 29.96–14.59 3.9 0.712
Pig ECM 4 7.18 20.92–15.27 13.1 0.082
Goat GF 2 7.31 226.40–41.02 14.1 0.671
Maxilla GF 2 216.95 251.80–17.89 229.7 0.340
Mandible Inorganic 4 13.68 8.43–18.93 34.2 <0.001*
Mandible GF 3 28.99 240.28–22.30 215.9 0.573
Mandible Peptide 4 6.74 23.02–16.49 12.8 0.176
Mandible ECM 8 10.36 3.45–17.26 21.3 0.003*
Skull GF 2 8.08 2.00–14.15 35.8 0.009*
Femur GF 2 7.31 226.40–41.02 14.1 0.671
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Table V summarizes the results separately for studies
performed in different anatomical locations. Studies were
only included if at least two studies per group were avail-
able. Statistically signiﬁcant differences were found for test
surfaces with inorganic surface coatings and ECM surface
coatings compared with reference surfaces in the mandible
and between test surfaces with GF surface coatings and ref-
erence surfaces for studies in skull bone. Studies using pep-
tide coatings in the mandible showed no signiﬁcant increase
in BIC.
Additional analysis
Results of Kappa measure for intraexaminer agreement GJ
and interexaminer agreement GJ–JJ/GJ–BS showed “very
good agreement” (Kappa 5 1.000). Results of Kappa mea-
sure of intraexaminer agreement JJ and interexaminer agree-
ment JJ–GJ/JJ–BS showed “good agreement”
(Kappa 5 0.732–0.839). Results of the McNemar test
between all examiners showed “no evidence for dis-
agreement” (McNemar 5 0.250–1.000).
DISCUSSION
Effect of coating
This systematic review and meta-analysis evaluated whether
biological implant surface coatings are capable of increasing
periimplant bone formation in comparison to uncoated tita-
nium surfaces in large animals. Twenty-four of the 30 stud-
ies were published between 2008 and 2013, indicating that
this topic is gaining interest. A major ﬁnding of this meta-
analysis is that biological implant surface coatings in general
increase bone formation. The meta-analysis revealed an
overall increase of 3.7 pp BIC. Considering the different sub-
groups of surface coatings, the summary effect size increase
was signiﬁcant for inorganic surfaces (15 pp) and ECM
surfaces (10 pp) and showed a statistical trend for peptide
surfaces (7 pp). Interestingly, GF coatings showed a mean
decrease in BIC of 3 pp.
Inorganic coatings showed the highest increase in BIC in
this meta-analysis. The inorganic surface group consisted of
CaP coatings (four studies23,26–28) and HA coatings (four
studies22,26,29,30). The results of this group need to be inter-
preted with caution, as only studies comparing inorganic
coatings to organic coatings were included in this review.
Studies solely comparing inorganic coatings to uncoated
surfaces were not included. For this reason, the data of inor-
ganic coatings are not representative for their general effect
and do not allow a general statement on their effect.
Still, the direct comparison of the used inorganic coat-
ings to the organic ones is possible and shows that in this
setting only the inorganic coatings and the ECM coatings
had a signiﬁcant effect on the BIC. It is difﬁcult to speculate
on the why as the actual processes and interactions that
take place during their osseointegration are not completely
understood.31 One reason may be the added structural
effects of such coatings, as morphological changes are
known to inﬂuence cell behavior,32 and both peptide and GF
coatings do not contribute to this aspect. Another possibility
is direct and receptor-speciﬁc interactions between the coat-
ings and cells. This is possible for both ECM and peptide
coatings, with an advantage for ECM coatings as they pro-
vide a larger number and greater variation of possible inter-
action sites. This would agree with the ﬁnding of the
peptide coatings being slightly better than the GF coatings,
as the last generally provide no cell adhesion sites. Neither
do inorganic coatings, at least not directly, but inorganic
coatings have a large protein binding capacity—larger than
a titanium surface, especially one precoated with GF or pep-
tide9,30—and may thus very well interact indirectly with
cells via binding the respective protein components. Yet, a
third possibility is also based on the interaction capacity of
the surfaces, in this case with soluble factors like cytokines
and growth factors that are secreted during tissue healing.
These factors can speciﬁcally bind to matrix proteins in
vivo, which can serve to potentiate their function.33 If these
factors are bound and retained by implant surfaces even for
a short time, this may serve to enhance their function and
thus the effect of the surface on the surrounding bone.
Some organic surface coatings are being designed to speciﬁ-
cally exploit this effect, and future studies will show how
much this can contribute to bone healing. Currently, the rel-
ative contributions of these possible mechanisms are not
known, though it may well turn out that no single one dom-
inates in the effect on BIC.
The surprisingly low performance of growth factor coat-
ings may be unexpected as most studies used BMP-2 as a
coating protein (seven studies in meta-analysis—Table IV,
11 studies in the entire review—Table II), which is well
known to stimulate bone growth even in critical size
defects.34 That no such stimulation of bone growth takes
place when BMP-2 is used as a coating may be based on the
much smaller amounts that can be immobilized on implant
surfaces compared to the carrier-based application in bone
defects as BMP amounts of coatings are in the mg range,
those of carriers in the mg range. Also, it is possible that GF
activity is reduced due to the immobilization pro-
cess.9,10,15,16,19,23–25,28,35–37 The same considerations apply
to the other growth factors used (Table III), perhaps even to
a greater degree as their effects on bone growth can be
expected to be generally lower than that of BMP.38 There
was only one exception to the negligible effect of GF on BIC
that can be seen if only pig models are considered (see
later).
Effect of animal model
A number of different animal models were used in the stud-
ies, which implies different dynamics of bone formation
especially in early healing intervals.39 This in turn may have
consequences for the observed BIC. For this reason, the dif-
ference in BIC was analyzed individually for the most com-
monly applied animal models (dog and pig).
While inorganic coatings showed a comparable increase
of BIC in both models with 14 pp in dogs and 15 pp in
pigs, there were differences for the other surfaces studied.
In dogs, both ECM coatings (13 pp) and peptide coatings
(11 pp) showed a signiﬁcant increase in BIC; in pigs, ECM
coatings only showed a statistical trend (7 pp), while
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peptide coatings (2 pp) clearly failed to attain a level of sig-
niﬁcance. For growth factor coatings, the situation was
reversed, as dog studies showed a mean decrease in BIC
and pig studies on the other hand showed a signiﬁcant
increase (6 pp).
One reason for the observed differences could be the
usually faster bone regeneration in dogs compared to pigs
and humans. To highlight different dynamics and levels of
bone formation in the two models, the relative BIC increase
(summary relative effect) was also calculated and analyzed
as it gives a better idea of the degree of the change since it
takes the absolute level of BIC into account. A 10 pp
increase over a 10–20 pp reference BIC is thus rated differ-
ently compared to the same increase over an 80–90 pp ref-
erence BIC, so the relative effect takes the inﬂuence of the
chosen animal model better into account. As an example,
ECM coatings showed a mean BIC increase (summary effect
size) of 10 pp: 13 pp in dogs and 7 pp in pigs. The sum-
mary relative effect of these ECM coatings in comparison to
controls, on the other hand, was 21 pp: 36 pp in dogs and
13 pp in pigs. With the exception of GF-coatings, all sub-
groups showed larger leverage effects in dog studies.
The absolute BIC showed clear differences in the effect
of different types of surface coatings depending on the ani-
mal model. Even taking animal-based variations into
account by calculating the summary relative effect, these
differences remain, indicating that they may be based on
different responses to different coating types.
Effect of location
Another factor of inﬂuence on bone formation is the ana-
tomical location, as bone quality and bone formation
dynamics differ between different localizations. For this
reason, surface subgroups were also analyzed with regard
to the anatomical site. The difference between extraoral
and intraoral locations could only be analyzed for inor-
ganic and GF coatings, as there were not enough studies to
determine the necessary values for ECM and peptide coat-
ings in extraoral locations. Inorganic coatings showed a
signiﬁcant increase in BIC for both locations of about
15 pp; the summary relative effect increase was twice as
high for extraoral locations (68 pp) compared to intraoral
ones (38 pp). For GF coatings, BIC increased for extraoral
locations (7 pp BIC and 18.5 pp summary relative effect
BIC) and decreased for intraoral ones (212 pp BIC and
221 pp summary relative effect BIC), but both changes
were not signiﬁcant. The BIC values for ECM and peptide
coatings in intraoral locations followed the trend observed
throughout the study with a signiﬁcant increase for ECM
coatings (10 pp BIC and 20 pp summary relative effect
BIC) and a nonsigniﬁcant increase for peptide coatings
(7 pp BIC and 13 pp summary relative effect BIC), Table
IV. Based on the results presented here, there does not
seem to be a major effect of location on the BIC, though
this is a tentative conclusion as only inorganic coatings
and GF coatings could be compared.
Effect of reference surface
It has often been shown that microrough surfaces promote
more bone formation in comparison to polished surfaces.5
As the inclusion criteria of this systematic review were only
the presence of an uncoated titanium reference surface, this
encompassed polished or machined surfaces as well as any
kind of microrough surface. To prevent a false positive
result due to the inclusion of smooth surfaces, we sepa-
rately evaluated those studies that used a microrough tita-
nium reference surface (13 of the 19 studies of the meta-
analysis). This analysis supported the overall trend as it
also showed a signiﬁcant increase in BIC only for inorganic
and ECM coatings.
LIMITATIONS
The aim of this systematic review was to give an overview
on large animal studies investigating the effect of biological
implant surface coatings on periimplant bone formation.
Furthermore, this review was combined with a meta-
analysis for the quantiﬁcation of the general effect of such
coatings on the BIC. The majority of the studies investigated
surface coatings with ECM components (especially collagen
type I) and growth factors (mostly BMP-2). There are fewer
studies applying peptides. The meta-analysis focused on the
possible effect of biological implant surfaces coatings on
BIC. Most of the biological surface coatings showed signiﬁ-
cant higher BIC values when compared to controls. The Fun-
nel plot results show that studies, which were selected and
included, may represent too positive results. The most com-
mon large animal models were dog and pig models. All of
the 30 studies used healthy animals, and no systemically
impaired animal model was applied. However, some studies
applied local defect models. This demonstrates that only
few studies analyze implant surface coatings under
impaired healing conditions. This is of interest, as in gen-
eral, there are multiple studies analyzing implants under
locally compromised conditions.40 Since there already is a
high clinical implant success rates in unimpaired bone,41,42
it might be of higher clinical interest to analyze new implant
surfaces under more critical circumstances, for example,
under the inﬂuence of bone augmentation procedures. From
a scientiﬁc point of view, it needs to be mentioned that this
makes the interpretation of the results more complicated as
further factors of inﬂuence will be introduced in such a
study.
Another factor of inﬂuence is the mode and time of heal-
ing. All studies analyzed unloaded implants, and 29 of the
30 studies used submerged healing. Nevertheless, implant
healing time showed large variations ranging from 7 to 168
days. Whereas some studies evaluate a single time point,
others evaluated up to three time points. Clinically relevant
time points are the ﬁrst early time points, as this may corre-
late with possible time points of implant loading. Other
inﬂuencing factors are implant-related parameters. Effects
of implant materials, surface, and design inﬂuence bone for-
mation.43 The single studies show large variations in the
number of applied implants. Most studies applied screw-
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shaped implants with differences in implant length and
diameter. Also, the methods of bone formation analysis dif-
fered. Twenty-six of the 30 studies used histology, mostly
combined with histomorphometry. Eleven studies used radi-
ographic means, and only four studies used biomechanics.
For this reason, the meta-analysis was based purely on BIC
measurements. All of these different factors of inﬂuence
complicate any interstudy comparison.
CONCLUSION
In this systematic review and meta-analysis, we could not
ﬁnd a general statistically signiﬁcant effect of the biological
implant surface coating on periimplant bone growth in large
animal models. Taking only studies in consideration, where
inorganic or ECM coatings were used, a signiﬁcant effect
could be observed. Whether this positive effect translates to
humans and whether this statistical signiﬁcant effect proves
clinical relevance need to be answered in prospective clini-
cal studies.
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